Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 396.00
+1.50 (0.38%)
Oct 8, 2026, 12:01 PM CST
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 21.57 billion as of October 8, 2026. It is the 12,779th most valuable company in the world and the 429th biggest in Taiwan. Its market cap has increased by 0.76% in one year.
Market Cap
21.57B
Enterprise Value
20.88B
Revenue
2.19B
Global Rank
Country Rank
#429 Taiwan
PE Ratio
26.51
ChartMarket Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.57B, an increase of 1,350.31%. That is a compound annual growth rate of 17.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 21.57B | - |
| Dec 31, 2025 | 21.57B | 41.43% |
| Dec 30, 2024 | 15.25B | 37.25% |
| Dec 29, 2023 | 11.11B | 50.00% |
| Dec 30, 2022 | 7.41B | 64.65% |
| Dec 30, 2021 | 4.50B | 2.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 25.79B |
| Oneness Biotech | 22.58B |
| Medigen Vaccine Biologics | 19.86B |
| Steminent Biotherapeutics | 17.36B |
| TaiMed Biologics | 16.39B |
| Ever Supreme Bio Technology | 16.12B |
| Gongwin Biopharm Holdings | 15.32B |
| EirGenix | 15.20B |